Norway vs Saudi Arabia: Life science patents granted, by technology
Norway
16 patents
in 2023
Saudi Arabia
14 patents
in 2023
Norway rank
32nd
Saudi Arabia rank
35th
Life science patents granted, by technology over time
- Norway
- Saudi Arabia
How they compare
Norway currently reports 16 patents against 14 patents in Saudi Arabia, a difference of 2 patents.
That makes Norway's figure about 1.1 times Saudi Arabia's.
Across all 21 years both countries report, Norway has been ahead every year.
Norway ranks 32nd and Saudi Arabia ranks 35th of 65 countries.
Norway has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Norway | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 276 patents | 5 patents | 271 patents | Norway |
| 2000s | 234.22 patents | 33.67 patents | 200.56 patents | Norway |
| 2010s | 179.25 patents | 7.75 patents | 171.5 patents | Norway |
| 2020s | 20.33 patents | 7.33 patents | 13 patents | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher life science patents granted, by technology, Norway or Saudi Arabia?
- Norway, at 16 patents against 14 patents in Saudi Arabia as of 2023.
- What is the difference in life science patents granted, by technology between Norway and Saudi Arabia?
- 2 patents, with Norway ahead.
- How many years of comparable data are there for Norway and Saudi Arabia?
- 21 years are reported by both, from 1999 to 2023.
- How do Norway and Saudi Arabia rank globally for life science patents granted, by technology?
- Norway ranks 32nd and Saudi Arabia ranks 35th of 65 countries.
- Where does this data come from?
- World Intellectual Property Organization (WIPO) (2025) β processed by Our World in Data, published as Life science patents granted, by technology. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of pharmaceutical patents granted by the filing office in a given year. Pharmaceutical patents typically cover new drugs, biological treatments or vaccines.